Dermatol. praxi. 2024;18(1):5-9 | DOI: 10.36290/der.2024.001

Bacterial skin infection II. - infection induced by gram-negative bacteria

doc. MUDr. Ondřej Kodet, Ph.D.
Dermatovenerologická klinika, 1. LF UK a VFN, Praha
Anatomický ústav, 1. LF UK, Praha

This review provides a brief overview of skin bacterial infections caused by gram-negative bacteria. These infections are less common and can have a rich clinical picture and differential diagnosis. Pseudomonas aeruginosa infection is among the most common skin infections caused by gram-negative bacteria. Among other infections, we can mention manifestations in severe acute, but also chronic, meningococcal infections, or skin lesions caused by the bacterium Bartonella henselae.

Keywords: gram-negative infections, pseudomonad infections, meningococcal infections, cat-scratch disease, tularemia.

Accepted: March 26, 2024; Published: April 3, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kodet O. Bacterial skin infection II. - infection induced by gram-negative bacteria. Dermatol. praxi. 2024;18(1):5-9. doi: 10.36290/der.2024.001.
Download citation

References

  1. Ungor I, Apidianakis Y. Bacterial synergies and antagonisms affecting Pseudomonas aeruginosa virulence in the human lung, skin and intestine. Future Microbiol. [Internet]. 2023 Oct 16 [cited 2024 Feb 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/37843410/. Go to original source... Go to PubMed...
  2. Spernovasilis N, Psichogiou M, Poulakou G. Skin manifestations of Pseudomonas aeruginosa infections. Curr Opin Infect Dis. [Internet]. 2021;34(2):72-79. [cited 2024 Feb 6]. Available from: https://pubmed.ncbi.nlm.nih.gov/33492004/. Go to original source... Go to PubMed...
  3. Chiriac A, Brzezinski P, Foia L, et al. Chloronychia: Green nail syndrome caused by Pseudomonas aeruginosa in elderly persons. Clin Interv Aging. 2014;10:265-267. Go to original source... Go to PubMed...
  4. Schwartz R, Reynoso-Vasquez N, Kapila R. Chloronychia: The Goldman-Fox Syndrome - Implications for Patients and Healthcare Workers. Indian J Dermatol. [Internet]. 2020;65(1): 1-4. [cited 2024 Feb 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/32029931/. Go to original source... Go to PubMed...
  5. Agger WA, Mardan A. Pseudomonas aeruginosa infections of intact skin. Clinical Infectious Diseases. 1995;20(2):302-308. Go to original source... Go to PubMed...
  6. Spernovasilis N, Psichogiou M, Poulakou G. Skin manifestations of Pseudomonas aeruginosa infections. Curr Opin Infect Dis. [Internet]. 2021;34(2):72-79. [cited 2024 Feb 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/33492004/. Go to original source... Go to PubMed...
  7. Wu DC, Chan WW, Metelitsa AI, Fiorillo L, et al. Pseudomonas skin infection: clinical features, epidemiology, and management. Am J Clin Dermatol. [Internet]. 2011;12(3):157-169. [cited 2024 Feb 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/21469761/. Go to original source... Go to PubMed...
  8. Zichichi L, Asta G, Noto G. Pseudomonas aeruginosa folliculitis after shower/bath exposure. Int J Dermatol. 2000;39(4):270-273. Go to original source... Go to PubMed...
  9. Zvulunov A, Trattner A, Naimer S. Pseudomonas hot-foot syndrome. N Engl J Med. [Internet]. 2001;345(22):1643-1644. [cited 2024 Feb 19]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11757518. Go to original source... Go to PubMed...
  10. Korte AKM, Vos JM. Ecthyma Gangrenosum. N Engl J Med. [Internet]. 2017;377(23):e32. [cited 2023 Oct 31]. Available from: https://pubmed.ncbi.nlm.nih.gov/29211664/. Go to original source... Go to PubMed...
  11. McHugh JW, Lehman JS, Shah A. Pseudomonas aeruginosa-Associated Ecthyma Gangrenosum: A Classic Presentation. Mayo Clin Proc. [Internet]. 2024;99(2):336-337. [cited 2024 Feb 6]. Available from: https://pubmed.ncbi.nlm.nih.gov/38309940/. Go to original source... Go to PubMed...
  12. Brouwer MC, Read RC, van de Beek D. Host genetics and outcome in meningococcal disease: a systematic review and meta-analysis. Lancet Infect Dis. [Internet]. 2010;10(4):262-274. [cited 2024 Feb 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/20334849/. Go to original source... Go to PubMed...
  13. Lécuyer H, Borgel D, Nassif X, et al. Pathogenesis of meningococcal purpura fulminans. Pathog Dis. [Internet]. 2017;75(3). [cited 2024 Feb 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/28334263/. Go to original source... Go to PubMed...
  14. Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet [Internet]. 2007 Jun 30;369(9580):2196-2210. [cited 2024 Feb 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/17604802/. Go to original source... Go to PubMed...
  15. Rouphael NG, Stephens DS. Neisseria meningitidis: Biology, microbiology, and epidemiology. Methods in Molecular Biology. 2012;799:1-20. Go to original source... Go to PubMed...
  16. Rosenstein NE, Perkins BA, Stephens DS, et al. Meningococcal disease. N Engl J Med. [Internet]. 2001;344(18):1378-1388. 3 [cited 2024 Feb 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/11333996/. Go to original source... Go to PubMed...
  17. Iba T, Watanabe E, Umemura Y, et al. Sepsis-associated disseminated intravascular coagulation and its differential diagnoses. Journal of Intensive Care 2019 7:1 [Internet]. 2019;7(1):1-13. [cited 2024 Feb 19]. Available from: https://jintensivecare.biomedcentral.com/articles/10.1186/s40560-019-0387-z. Go to original source... Go to PubMed...
  18. Wenzel M, Jakob L, Wieser A, Schubert S, et al. Corticosteroid-induced meningococcal meningitis in a patient with chronic meningococcemia. JAMA Dermatol [Internet]. 2014;150(7):752-755. [cited 2024 Feb 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/24577072/. Go to original source... Go to PubMed...
  19. George CRR, Smith HV, Lahra MM. Neisseria Meningitidis. Molecular Typing in Bacterial Infections, Volume I: Second Edition [Internet]. 2022;1:85-99. [cited 2024 Feb 19]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK549849/ Go to original source...
  20. Arreaza L, De La Fuente L, Vázquez JA. Antibiotic susceptibility patterns of Neisseria meningitidis isolates from patients and asymptomatic carriers. Antimicrob Agents Chemother [Internet]. 2000;44(6):1705-1707. [cited 2024 Feb 19]. Available from: https://journals.asm.org/journal/aac. Go to original source... Go to PubMed...
  21. Borrow R, Martinón-Torres F, Abitbol V, et al. Use of expanded Neisseria meningitidis serogroup B panels with the serum bactericidal antibody assay for the evaluation of meningococcal B vaccine effectiveness. Expert Rev Vaccines. [Internet]. 2023;22(1):738-748. [cited 2024 Feb 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/37622470/. Go to original source... Go to PubMed...
  22. Gardner P. Clinical practice. Prevention of meningococcal disease. N Engl J Med. [Internet]. 2006;355(14):1466-1473. [cited 2024 Feb 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/17021322/. Go to original source... Go to PubMed...
  23. Iannino F, Salucci S, Di Provvido A, et al. Bartonella infections in humans dogs and cats. Vet Ital [Internet]. 2018;54(1):63-72. [cited 2024 Feb 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/29631316/.
  24. Mazur-Melewska K, Mania A, Kemnitz P, et al. Cat-scratch disease: a wide spectrum of clinical pictures. Postepy Dermatol Alergol [Internet]. 2015;32(3):216-220. [cited 2024 Feb 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/26161064/. Go to original source... Go to PubMed...
  25. Asano S. Granulomatous lymphadenitis. J Clin Exp Hematop. [Internet]. 2012;52(1):1-16. [cited 2024 Feb 19] Available from: https://pubmed.ncbi.nlm.nih.gov/22706525/. Go to original source... Go to PubMed...
  26. McCormick DW, Rassoulian-Barrett SL, Hoogestraat DR, et al. Bartonella spp. Infections Identified by Molecular Methods, United States. Emerg Infect Dis. [Internet]. 2023;29(3):467-476. [cited 2024 Feb 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/36823096/. Go to original source... Go to PubMed...
  27. Chomel BB. Cat-scratch disease and bacillary angiomatosis. Rev Sci Tech. [Internet]. 1996;15(3):1061-1073. [cited 2024 Feb 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/9025151/. Go to original source... Go to PubMed...
  28. Thomas LD, Schaffner W. Tularemia Pneumonia. Infect Dis Clin North Am. 2010;24(1):43-55. Go to original source... Go to PubMed...
  29. Feldman KA. Tularemia. J Am Vet Med Assoc [Internet]. 2003;222(6):725-730. [cited 2024 Feb 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/12675294/. Go to original source... Go to PubMed...
  30. Faber M, Heuner K, Jacob D, et al. Tularemia in Germany-A Re-emerging Zoonosis. Front Cell Infect Microbiol [Internet]. 2018;8. [cited 2024 Feb 19] Available from: https://pubmed.ncbi.nlm.nih.gov/29503812/. Go to original source... Go to PubMed...




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.